Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Acta Physiological Sinica》 1991-02
Add to Favorite Get Latest Update


MEI LIN;HAN JI-SHENG(Department of Physiology,Beijing Medical University,Beijing100083)  
Cholecystokinin-octapeptide(CCK-8)has been shown to antagonize the an-algesia produced by opioid peptides.The present study was performed to evaluateits effect on cardiovascular regulatory functions of opioids.Both CCK-8 and opioidpeptides were injected intrathecally(ith)in pentobarbital anaesthetized rats.Thedepressive effects induced by the mu agonist PL017(5 μg)delta agonist DADLE(25 μg)and kappa agonist 66A-078(1 μg)were antagonized by CCK-8 within adosage of 10μg in a dose dependent manner.CCK-8 can also partly antagonizethe bradycardiac effects induced by PL017,DADLE and 66A-078.The antagonistic effect of CCK-8 on DADLE in MAP could be reversed bypretreatment with CCK receptor antagonist proglumide(100μg).No significantchanges in MAP were found following ith administration of CCK-8 0.5-10μgand proglumide 100 μg,but a large dose(50μg)of CCK-8 lowered MAP dra-matically.The results suggest that within a certain range of dose CCK-8 in spinal cordmay play an antagonistic role against opioid effects in the regulation of cardio-vascular function and this effect of CCK-8 seems to be mediated by CCK recep-tor.These results support the hypothesis that CCK-8 may act as an anti-opioidsubstance in the CNS of the rat.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved